These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19106274)

  • 1. The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes.
    Schwarz PE; Li J; Reimann M; Schutte AE; Bergmann A; Hanefeld M; Bornstein SR; Schulze J; Tuomilehto J; Lindström J
    J Clin Endocrinol Metab; 2009 Mar; 94(3):920-6. PubMed ID: 19106274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of undiagnosed type 2 diabetic individuals by the finnish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish men.
    Wang J; Stancáková A; Kuusisto J; Laakso M
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3858-62. PubMed ID: 20463095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population.
    Bergmann A; Li J; Wang L; Schulze J; Bornstein SR; Schwarz PE
    Horm Metab Res; 2007 Sep; 39(9):677-82. PubMed ID: 17846976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Finnish Diabetes Risk Score is associated with insulin resistance but not reduced β-cell function, by classical and model-based estimates.
    Brodovicz KG; Dekker JM; Rijkelijkhuizen JM; Rhodes T; Mari A; Alssema M; Nijpels G; Williams-Herman DE; Girman CJ
    Diabet Med; 2011 Sep; 28(9):1078-81. PubMed ID: 21843304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validation of the FINDRISC (FINnish Diabetes RIsk SCore) for prediction of the risk of type 2 diabetes in a population of southern Spain. Pizarra Study].
    Soriguer F; Valdés S; Tapia MJ; Esteva I; Ruiz de Adana MS; Almaraz MC; Morcillo S; García Fuentes E; Rodríguez F; Rojo-Martinez G
    Med Clin (Barc); 2012 Apr; 138(9):371-6. PubMed ID: 21939990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
    Salinero-Fort MA; Burgos-Lunar C; Lahoz C; Mostaza JM; Abánades-Herranz JC; Laguna-Cuesta F; Estirado-de Cabo E; García-Iglesias F; González-Alegre T; Fernández-Puntero B; Montesano-Sánchez L; Vicent-López D; Cornejo-Del Río V; Fernández-García PJ; Sánchez-Arroyo V; Sabín-Rodríguez C; López-López S; Patrón-Barandio P; Gómez-Campelo P;
    PLoS One; 2016; 11(7):e0158489. PubMed ID: 27441722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study.
    Hellgren MI; Petzold M; Björkelund C; Wedel H; Jansson PA; Lindblad U
    Diabet Med; 2012 Dec; 29(12):1501-5. PubMed ID: 22443428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validating the CANRISK prognostic model for assessing diabetes risk in Canada's multi-ethnic population.
    Robinson CA; Agarwal G; Nerenberg K
    Chronic Dis Inj Can; 2011 Dec; 32(1):19-31. PubMed ID: 22153173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Finnish Diabetes Risk Score (FINDRISC) as a screening tool for hepatic steatosis.
    Carvalho JA; Barengo NC; Tuomilehto J; Conceição RD; Santos RD
    Ann Med; 2011; 43(6):487-94. PubMed ID: 21604917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece.
    Makrilakis K; Liatis S; Grammatikou S; Perrea D; Stathi C; Tsiligros P; Katsilambros N
    Diabetes Metab; 2011 Apr; 37(2):144-51. PubMed ID: 21144787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epicardial adipose tissue thickness and type 2 diabetes risk according to the FINDRISC modified for Latin America.
    Lima-Martínez MM; Colmenares L; Campanelli Y; Paoli M; Rodney M; Santos RD; Iacobellis G
    Clin Investig Arterioscler; 2019; 31(1):15-22. PubMed ID: 30166212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Finnish Type 2 Diabetes Risk Score (FINDRISC) with the OGTT in Health Care Practices in Europe.
    Gabriel R; Acosta T; Florez K; Anillo L; Navarro E; Boukichou N; Acosta-Reyes J; Barengo NC; Lindström J; Tuomilehto JO; Aschner P
    Diabetes Res Clin Pract; 2021 Aug; 178():108976. PubMed ID: 34302911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes.
    Tankova T; Chakarova N; Atanassova I; Dakovska L
    Diabetes Res Clin Pract; 2011 Apr; 92(1):46-52. PubMed ID: 21242013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A more simplified Finnish diabetes risk score for opportunistic screening of undiagnosed type 2 diabetes in a German population with a family history of the metabolic syndrome.
    Li J; Bergmann A; Reimann M; Bornstein SR; Schwarz PE
    Horm Metab Res; 2009 Feb; 41(2):98-103. PubMed ID: 18975253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a screening tool using electronic health records for undiagnosed Type 2 diabetes mellitus and impaired fasting glucose detection in the Slovenian population.
    Štiglic G; Kocbek P; Cilar L; Fijačko N; Stožer A; Zaletel J; Sheikh A; Povalej Bržan P
    Diabet Med; 2018 May; 35(5):640-649. PubMed ID: 29460977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome.
    Saaristo T; Peltonen M; Lindström J; Saarikoski L; Sundvall J; Eriksson JG; Tuomilehto J
    Diab Vasc Dis Res; 2005 May; 2(2):67-72. PubMed ID: 16305061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in occupational health care.
    Vandersmissen GJ; Godderis L
    Int J Occup Med Environ Health; 2015; 28(3):587-91. PubMed ID: 26190733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation of three diabetes prediction scores in a Spanish cohort: does adding high risk for depression improve the validation of the FINDRISC score (FINDRISC-MOOD)?
    Salinero-Fort M; Mostaza-Prieto JM; Lahoz-Rallo C; Cárdenas-Valladolid J; Iriarte-Campo V; Estirado-Decabo E; Garcia-Iglesias F; Gonzalez-Alegre T; Fernandez-Puntero B; Cornejo-Del Rio VM; Sanchez-Arroyo V; Sabín-Rodríguez C; López-López S; Gómez-Campelo P; Taulero-Escalera B; Rodriguez-Artalejo F; San Andrés-Rebollo FJ; De Burgos-Lunar C;
    BMJ Open; 2024 Jun; 14(6):e083121. PubMed ID: 38844393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.
    Wilson PW; Meigs JB; Sullivan L; Fox CS; Nathan DM; D'Agostino RB
    Arch Intern Med; 2007 May; 167(10):1068-74. PubMed ID: 17533210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic finnish offspring of type 2 diabetic individuals.
    Lorenzo C; Haffner SM; Stancáková A; Laakso M
    J Clin Endocrinol Metab; 2010 Nov; 95(11):5082-90. PubMed ID: 20702522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.